Juan Pablo Alderuccio, MD

Articles by Juan Pablo Alderuccio, MD

Oncology Peer Review On-The-Go: Current Treatments in Marginal Zone Lymphoma

August 9th 2022

Juan Pablo Alderuccio, MD, spoke with CancerNetwork® about a review article on the treatment of marginal zone lymphoma published in the journal ONCOLOGY®.

Current Treatments in Marginal Zone Lymphoma

ByJuan Pablo Alderuccio, MD,Brad S. Kahl, MD

April 18th 2022

This review provides an updated analysis of the literature and discusses the authors' approach to the diagnosis and treatment of patients with marginal zone lymphoma.

Latest Updated Articles

Current Treatments in Marginal Zone Lymphoma
April 18th 2022
Oncology Peer Review On-The-Go: Current Treatments in Marginal Zone Lymphoma
August 9th 2022

Trending on CancerNetwork

FDA Approves Zenocutuzumab in NRG1+ Cholangiocarcinoma Post Systemic Therapy

Daraxonrasib Shows Anti-Tumor Activity in Pretreated RAS+ Pancreatic Cancer

FDA Clears AI Stratification Tool in HR+/HER2– Invasive Breast Cancer

Achieving a “Functional Cure” With Multiple Myeloma Therapy

TIP125 ReDiscover-2, a Phase 3 Study of Zovegalisib (RLY-2608) + Fulvestrant Versus Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-Mutant HR+/ HER2- Breast Cancer Following Recurrence or Progression on or After Treatment With a CDK4/6 Inhibitor (Trial in Progress)